![Christopher O’Donnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher O’Donnell
Director/Board Member at
Adapsyn Bioscience, Inc.
Profile
Dr. Christopher O’Donnell is a Vice President & Partner at Pfizer Venture Investments LLC.
He is on the Board of Directors at Adapsyn Bioscience, Inc., Arkuda Therapeutics, Inc., Incendia Therapeutics, Inc., STORM Therapeutics Ltd., Strata Oncology, Inc. and TRIANA Biomedicines, Inc.
Dr. O’Donnell also served on the board at Pyxis Oncology, Inc. and Kymera Therapeutics, Inc.
He received his undergraduate degree from the University of Illinois At Urbana–Champaign and a doctorate degree from the University of Wisconsin.
Christopher O’Donnell active positions
| Companies | Position | Start |
|---|---|---|
Adapsyn Bioscience, Inc.
 Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focussed on the discovery and development of novel medicines | Director/Board Member | - |
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing medicines to improve the lives of patients with neurological diseases | Director/Board Member | - |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Private Equity Investor | 28/02/2018 |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Director/Board Member | - |
Strata Oncology, Inc.
 Strata Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs | Director/Board Member | - |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Director/Board Member | - |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Director/Board Member | - |
Former positions of Christopher O’Donnell
| Companies | Position | End |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Director/Board Member | 30/09/2021 |
| KYMERA THERAPEUTICS, INC. | Director/Board Member | - |
Training of Christopher O’Donnell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Venture Investments LLC
Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Finance |
Strata Oncology, Inc.
Strata Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs | Health Technology |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecule drugs through RNA biology for the treatment of cancer, inflammation, viruses and CNS diseases | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focussed on the discovery and development of novel medicines | Health Technology |
Arkuda Therapeutics, Inc.
Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing medicines to improve the lives of patients with neurological diseases | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
Incendia Therapeutics, Inc.
Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel class of anti-cancer therapies | Health Technology |
- Stock Market
- Insiders
- Christopher O’Donnell
